At Fosun Health, colorectal cancer diagnosis must answer three questions simultaneously: Where is the tumor? How deep has it invaded? Has it spread to the liver or lungs? Our integrated pathway delivers all answers rapidly:
The gold standard. We perform high-definition chromoendoscopy or NBI (Narrow Band Imaging) to detect flat lesions and early cancers. Tissue biopsy confirms histology and grade.
For rectal cancer, this is the most critical scan. It reveals the tumor's exact distance from the anal sphincter, its relationship to the mesorectal fascia (CRM), and the presence of extramural venous invasion—directly determining whether sphincter preservation is possible.
Maps the entire abdominal cavity, evaluating liver metastases, lung nodules, peritoneal implants, and lymph node status.
Detects hidden metastases and confirms accurate TNM stage classification.
Using NGS (Next-Generation Sequencing)，we analyze RAS (KRAS/NRAS), BRAF, HER2, MSI/dMMR status, and over 300 cancer-related genes. This determines your eligibility for anti-EGFR targeted therapy, immunotherapy (for MSI-H/dMMR), or HER2-directed regimens—ensuring your treatment is matched to your tumor's biology, not a one-size-fits-all protocol.
